Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
Clinical trial NCT00070278 · UNKNOWN
Trial details
- NCT number
- NCT00070278
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2007-09-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.